210 related articles for article (PubMed ID: 23348519)
1. The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.
Felix AS; Cook LS; Gaudet MM; Rohan TE; Schouten LJ; Setiawan VW; Wise LA; Anderson KE; Bernstein L; De Vivo I; Friedenreich CM; Gapstur SM; Goldbohm RA; Henderson B; Horn-Ross PL; Kolonel L; Lacey JV; Liang X; Lissowska J; Magliocco A; McCullough ML; Miller AB; Olson SH; Palmer JR; Park Y; Patel AV; Prescott J; Rastogi R; Robien K; Rosenberg L; Schairer C; Ou Shu X; van den Brandt PA; Virkus RA; Wentzensen N; Xiang YB; Xu WH; Yang HP; Brinton LA
Br J Cancer; 2013 Feb; 108(3):727-34. PubMed ID: 23348519
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors.
Zelmanowicz A; Hildesheim A; Sherman ME; Sturgeon SR; Kurman RJ; Barrett RJ; Berman ML; Mortel R; Twiggs LB; Wilbanks GD; Brinton LA
Gynecol Oncol; 1998 Jun; 69(3):253-7. PubMed ID: 9648597
[TBL] [Abstract][Full Text] [Related]
3. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus.
Schwartz SM; Weiss NS; Daling JR; Gammon MD; Liff JM; Watt J; Lynch CF; Newcomb PA; Armstrong BK; Thompson WD
Cancer; 1996 Feb; 77(4):717-24. PubMed ID: 8616764
[TBL] [Abstract][Full Text] [Related]
4. Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case-control study.
Abril J; Trabert B; Troisi R; Grotmol T; Ekbom A; Engeland A; Gissler M; Glimelius I; Madanat-Harjuoja L; Gulbech Ording A; Sørensen HT; Tretli S; Bjørge T
Cancer Causes Control; 2024 May; 35(5):741-747. PubMed ID: 38129544
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
6. A clinical and biological comparison between malignant mixed müllerian tumors and grade 3 endometrioid endometrial carcinomas.
Bland AE; Stone R; Heuser C; Shu J; Jazaeri A; Shutter J; Atkins K; Rice L
Int J Gynecol Cancer; 2009 Feb; 19(2):261-5. PubMed ID: 19396006
[TBL] [Abstract][Full Text] [Related]
7. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of sarcomas of the uterus.
Harlow BL; Weiss NS; Lofton S
J Natl Cancer Inst; 1986 Mar; 76(3):399-402. PubMed ID: 3456457
[TBL] [Abstract][Full Text] [Related]
9. Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2).
Harvey SV; Wentzensen N; Bertrand K; Black A; Brinton LA; Chen C; Costas L; Dal Maso L; De Vivo I; Du M; Garcia-Closas M; Goodman MT; Gorzelitz J; Johnson L; Lacey JV; Liao L; Lipworth L; Lissowska J; Miller AB; O'Connell K; O'Mara TA; Ou X; Palmer JR; Patel AV; Paytubi S; Pelegrina B; Petruzella S; Prizment A; Rohan T; Sandin S; Setiawan VW; Sinha R; Trabert B; Webb PM; Wilkens LR; Xu W; Yang HP; Zheng W; Clarke MA
Int J Epidemiol; 2023 Aug; 52(4):1086-1099. PubMed ID: 37029916
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
12. Incidence of histologic types of uterine sarcoma in relation to menstrual and reproductive history.
Schwartz SM; Weiss NS; Daling JR; Newcomb PA; Liff JM; Gammon MD; Thompson WD; Watt JD; Armstrong BK; Weyer P
Int J Cancer; 1991 Sep; 49(3):362-7. PubMed ID: 1917134
[TBL] [Abstract][Full Text] [Related]
13. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
Felix AS; Gaudet MM; La Vecchia C; Nagle CM; Shu XO; Weiderpass E; Adami HO; Beresford S; Bernstein L; Chen C; Cook LS; De Vivo I; Doherty JA; Friedenreich CM; Gapstur SM; Hill D; Horn-Ross PL; Lacey JV; Levi F; Liang X; Lu L; Magliocco A; McCann SE; Negri E; Olson SH; Palmer JR; Patel AV; Petruzella S; Prescott J; Risch HA; Rosenberg L; Sherman ME; Spurdle AB; Webb PM; Wise LA; Xiang YB; Xu W; Yang HP; Yu H; Zeleniuch-Jacquotte A; Brinton LA
Int J Cancer; 2015 Mar; 136(5):E410-22. PubMed ID: 25242594
[TBL] [Abstract][Full Text] [Related]
15. Marital status and the incidence of sarcomas of the uterus.
Schwartz SM; Weiss NS
Cancer Res; 1990 Mar; 50(6):1886-9. PubMed ID: 2306740
[TBL] [Abstract][Full Text] [Related]
16. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients.
Arem H; Park Y; Pelser C; Ballard-Barbash R; Irwin ML; Hollenbeck A; Gierach GL; Brinton LA; Pfeiffer RM; Matthews CE
J Natl Cancer Inst; 2013 Mar; 105(5):342-9. PubMed ID: 23297041
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of malignant mixed mesodermal tumor: analysis of 50 cases].
Ding XH; Ma ZY; Wang YF; Dou FX; Yuan J; Tian X; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1008-1013. PubMed ID: 34496490
[No Abstract] [Full Text] [Related]
18. A case-control study of risk factors for sarcomas of the uterus. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
Schwartz SM; Thomas DB
Cancer; 1989 Dec; 64(12):2487-92. PubMed ID: 2684386
[TBL] [Abstract][Full Text] [Related]
19. Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.
Hosh M; Antar S; Nazzal A; Warda M; Gibreel A; Refky B
Int J Gynecol Cancer; 2016 Jul; 26(6):1098-104. PubMed ID: 27177280
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
